SCHEMBL5494824

SCHEMBL5494824

COc1ccc(C(=O)O)cc1NS(C)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MEN1 O00255 1/20 0.58
ALDH1A1 P00352 1/20 0.58
KMT2A Q03164 1/20 0.58
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA4 P22748 1/20 0.57
CA6 P23280 1/20 0.57
CA7 P43166 1/20 0.57
TPMT P51580 1/20 0.57
CA9 Q16790 1/20 0.57
CA14 Q9ULX7 1/20 0.57
POLB P06746 1/20 0.55
PKM P14618 1/20 0.55
TDP1 Q9NUW8 2/20 0.54
KDM4E B2RXH2 1/20 0.54
HSD17B10 Q99714 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071184 0.88 SMN1; SMN2 (0.70) ACLYSMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL5364834 0.88 SMN1; SMN2 (0.58) SMN1; SMN2MEN1ALDH1A1KMT2ACA12
SCHEMBL15662236 0.84 TSHR (0.56) SMN1; SMN2MEN1ALDH1A1KMT2APOLB
SCHEMBL7039348 0.82 ALDH1A1 (0.50) ACLYSMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL567311 0.82 NEU3 (0.63) SMN1; SMN2MEN1ALDH1A1KMT2AKDM4E
SCHEMBL29791247 0.82 NEU3 (0.63) SMN1; SMN2MEN1ALDH1A1KMT2AKDM4E
SCHEMBL3247653 0.81 ALDH1A1 (0.61) SMN1; SMN2MEN1ALDH1A1KMT2APOLB
SCHEMBL14799282 0.81 HPGD (0.59) SMN1; SMN2MEN1ALDH1A1KMT2ACA1
SCHEMBL2803800 0.80 MYC (0.50) SMN1; SMN2MEN1ALDH1A1KMT2AKDM4E
SCHEMBL2217939 0.80 CA12 (0.65) ACLYMEN1ALDH1A1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1984883-B Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies PROTEOTECH INC 2012-03-21 CN disclosed
CN-1984883-A Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies PROTEOTECH INC (US) 2007-06-20 CN disclosed
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP disclosed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO disclosed